866-997-4948(US-Canada Toll Free)

Global Opioid-Induced Constipation (OIC) Treatment Industry 2017, Trends and Forecast Report

Published By :

9Dimen Research

Published Date : Sep 2017

Category :

Equipment

No. of Pages : 165 Pages

Opioid-Induced Constipation (OIC) Treatment Report by Material, Application, and Geography Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

In this report, the global Opioid-Induced Constipation (OIC) Treatment market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021.

The report firstly introduced the Opioid-Induced Constipation (OIC) Treatment basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Takeda Pharmaceutical
Tongrentang
Pfizer
AIKO Biotechnology
GlaxoSmithKline
AstraZeneca


The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Naloxegol
Lubiprostone
Methylnaltrexone Bromide


On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Opioid-Induced Constipation (OIC) Treatment for each application, including-
Constipation
Appliaction B
Appliaction C
Table of Contents

Part I Opioid-Induced Constipation (OIC) Treatment Industry Overview

Chapter One Opioid-Induced Constipation (OIC) Treatment Industry Overview
1.1 Opioid-Induced Constipation (OIC) Treatment Definition
1.2 Opioid-Induced Constipation (OIC) Treatment Classification Analysis
Naloxegol
Lubiprostone
Methylnaltrexone Bromide

1.2.1 Opioid-Induced Constipation (OIC) Treatment Main Classification Analysis
1.2.2 Opioid-Induced Constipation (OIC) Treatment Main Classification Share Analysis
1.3 Opioid-Induced Constipation (OIC) Treatment Application Analysis
Constipation
Appliaction B
Appliaction C

1.3.1 Opioid-Induced Constipation (OIC) Treatment Main Application Analysis
1.3.2 Opioid-Induced Constipation (OIC) Treatment Main Application Share Analysis
1.4 Opioid-Induced Constipation (OIC) Treatment Industry Chain Structure Analysis
1.5 Opioid-Induced Constipation (OIC) Treatment Industry Development Overview
1.5.1 Opioid-Induced Constipation (OIC) Treatment Product History Development Overview
1.5.1 Opioid-Induced Constipation (OIC) Treatment Product Market Development Overview
1.6 Opioid-Induced Constipation (OIC) Treatment Global Market Comparison Analysis
1.6.1 Opioid-Induced Constipation (OIC) Treatment Global Import Market Analysis
1.6.2 Opioid-Induced Constipation (OIC) Treatment Global Export Market Analysis
1.6.3 Opioid-Induced Constipation (OIC) Treatment Global Main Region Market Analysis
1.6.4 Opioid-Induced Constipation (OIC) Treatment Global Market Comparison Analysis
1.6.5 Opioid-Induced Constipation (OIC) Treatment Global Market Development Trend Analysis

Chapter Two Opioid-Induced Constipation (OIC) Treatment Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Opioid-Induced Constipation (OIC) Treatment Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Opioid-Induced Constipation (OIC) Treatment Market Analysis
3.1 Asia Opioid-Induced Constipation (OIC) Treatment Product Development History
3.2 Asia Opioid-Induced Constipation (OIC) Treatment Competitive Landscape Analysis
3.3 Asia Opioid-Induced Constipation (OIC) Treatment Market Development Trend

Chapter Four 2012-2017 Asia Opioid-Induced Constipation (OIC) Treatment Productions Supply Sales Demand Market Status and Forecast
4.1 2012-2017 Opioid-Induced Constipation (OIC) Treatment Capacity Production Overview
4.2 2012-2017 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
4.3 2012-2017 Opioid-Induced Constipation (OIC) Treatment Demand Overview
4.4 2012-2017 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
4.5 2012-2017 Opioid-Induced Constipation (OIC) Treatment Import Export Consumption Analysis
4.6 2012-2017 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Chapter Five Asia Opioid-Induced Constipation (OIC) Treatment Key Manufacturers Analysis
5.1 Takeda Pharmaceutical
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value Analysis
5.1.5 Contact Information
5.2 Tongrentang
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value Analysis
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value Analysis
5.3.5 Contact Information
...
...
Chapter Six Asia Opioid-Induced Constipation (OIC) Treatment Industry Development Trend
6.1 2017-2021 Opioid-Induced Constipation (OIC) Treatment Capacity Production Trend
6.2 2017-2021 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
6.3 2017-2021 Opioid-Induced Constipation (OIC) Treatment Demand Trend
6.4 2017-2021 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
6.5 2017-2021 Opioid-Induced Constipation (OIC) Treatment Import Export Consumption Analysis
6.6 2017-2021 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Part III North American Opioid-Induced Constipation (OIC) Treatment Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Opioid-Induced Constipation (OIC) Treatment Market Analysis
7.1 North American Opioid-Induced Constipation (OIC) Treatment Product Development History
7.2 North American Opioid-Induced Constipation (OIC) Treatment Competitive Landscape Analysis
7.3 North American Opioid-Induced Constipation (OIC) Treatment Market Development Trend

Chapter Eight 2012-2017 North American Opioid-Induced Constipation (OIC) Treatment Productions Supply Sales Demand Market Status and Forecast
8.1 2012-2017 Opioid-Induced Constipation (OIC) Treatment Capacity Production Overview
8.2 2012-2017 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
8.3 2012-2017 Opioid-Induced Constipation (OIC) Treatment Demand Overview
8.4 2012-2017 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
8.5 2012-2017 Opioid-Induced Constipation (OIC) Treatment Import Export Consumption Analysis
8.6 2012-2017 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Chapter Nine North American Opioid-Induced Constipation (OIC) Treatment Key Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value Analysis
9.1.5 Contact Information
9.1 AIKO Biotechnology
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value Analysis
9.2.5 Contact Information
...
...
Chapter Ten North American Opioid-Induced Constipation (OIC) Treatment Industry Development Trend
10.1 2017-2021 Opioid-Induced Constipation (OIC) Treatment Capacity Production Trend
10.2 2017-2021 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
10.3 2017-2021 Opioid-Induced Constipation (OIC) Treatment Demand Trend
10.4 2017-2021 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
10.5 2017-2021 Opioid-Induced Constipation (OIC) Treatment Import Export Consumption Analysis
10.6 2017-2021 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Part IV Europe Opioid-Induced Constipation (OIC) Treatment Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Opioid-Induced Constipation (OIC) Treatment Market Analysis
11.1 Europe Opioid-Induced Constipation (OIC) Treatment Product Development History
11.2 Europe Opioid-Induced Constipation (OIC) Treatment Competitive Landscape Analysis
11.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Development Trend

Chapter Twelve 2012-2017 Europe Opioid-Induced Constipation (OIC) Treatment Productions Supply Sales Demand Market Status and Forecast
12.1 2012-2017 Opioid-Induced Constipation (OIC) Treatment Capacity Production Overview
12.2 2012-2017 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
12.3 2012-2017 Opioid-Induced Constipation (OIC) Treatment Demand Overview
12.4 2012-2017 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
12.5 2012-2017 Opioid-Induced Constipation (OIC) Treatment Import Export Consumption Analysis
12.6 2012-2017 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Chapter Thirteen Europe Opioid-Induced Constipation (OIC) Treatment Key Manufacturers Analysis
13.1 GlaxoSmithKline
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value Analysis
13.1.5 Contact Information
13.2 AstraZeneca
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value Analysis
13.2.5 Contact Information
...
...
Chapter Fourteen Europe Opioid-Induced Constipation (OIC) Treatment Industry Development Trend
14.1 2017-2021 Opioid-Induced Constipation (OIC) Treatment Capacity Production Trend
14.2 2017-2021 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
14.3 2017-2021 Opioid-Induced Constipation (OIC) Treatment Demand Trend
14.4 2017-2021 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
14.5 2017-2021 Opioid-Induced Constipation (OIC) Treatment Import Export Consumption Analysis
14.6 2017-2021 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Part V Opioid-Induced Constipation (OIC) Treatment Marketing Channels and Investment Feasibility

Chapter Fifteen Opioid-Induced Constipation (OIC) Treatment Marketing Channels Development Proposals Analysis
15.1 Opioid-Induced Constipation (OIC) Treatment Marketing Channels Status
15.2 Opioid-Induced Constipation (OIC) Treatment Marketing Channels Characteristic
15.3 Opioid-Induced Constipation (OIC) Treatment Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Opioid-Induced Constipation (OIC) Treatment New Project Investment Feasibility Analysis
17.1 Opioid-Induced Constipation (OIC) Treatment Market Analysis
17.2 Opioid-Induced Constipation (OIC) Treatment Project SWOT Analysis
17.3 Opioid-Induced Constipation (OIC) Treatment New Project Investment Feasibility Analysis

Part VI Global Opioid-Induced Constipation (OIC) Treatment Industry Conclusions

Chapter Eighteen 2012-2017 Global Opioid-Induced Constipation (OIC) Treatment Productions Supply Sales Demand Market Status and Forecast
18.1 2012-2017 Opioid-Induced Constipation (OIC) Treatment Capacity Production Overview
18.2 2012-2017 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
18.3 2012-2017 Opioid-Induced Constipation (OIC) Treatment Demand Overview
18.4 2012-2017 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
18.5 2012-2017 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Chapter Nineteen Global Opioid-Induced Constipation (OIC) Treatment Industry Development Trend
19.1 2017-2021 Opioid-Induced Constipation (OIC) Treatment Capacity Production Trend
19.2 2017-2021 Opioid-Induced Constipation (OIC) Treatment Production Market Share Analysis
19.3 2017-2021 Opioid-Induced Constipation (OIC) Treatment Demand Trend
19.4 2017-2021 Opioid-Induced Constipation (OIC) Treatment Supply Demand and Shortage Analysis
19.5 2017-2021 Opioid-Induced Constipation (OIC) Treatment Cost Price Production Value Profit Analysis

Chapter Twenty Global Opioid-Induced Constipation (OIC) Treatment Industry Research Conclusions

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *